Market Overview

Goldman Sachs Downgrades Cepheid from Buy to Neutral, Announces PT of $32

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CPHD

DateFirmActionFromTo
Apr 2015JMP SecuritiesMaintainsMarket Outperform
Dec 2014Bank of AmericaUpgradesNeutralBuy
Dec 2014CitigroupMaintainsBuy

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Downgrades Price Target Initiation Analyst Ratings

 

Related Articles (CPHD)

Around the Web, We're Loving...